Abstract
Global dengue cases rapidly rose to record levels in 2023-24. We investigated this trend in Valle del Cauca, Colombia to determine if specific dengue virus serotypes or lineages were responsible for the large outbreak. We detected all four serotypes and multiple lineages, suggesting that other factors, such as climatic conditions, are likely responsible.
Competing Interest Statement
NDG is a paid consultant for BioNTech.
Funding Statement
This publication was made possible by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) under Award Number DP2AI176740 (NDG) and an NIH Shared Equipment grant 1S10OD028669-01 award to the Yale Center for Genome Analysis. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the NIH.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Our study was approved by the Research Ethics Committee at HUV and Yale University Human Research Protection Program (Protocol ID: 2000033281) and all participants signed an informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
We fixed oversights in the authorship: added Pio Lopez from CEIP and corrected Eduardo Lopez-Medina's name
Data Availability
Our sequencing data can be found at NCBI BioProject PRJNA1132139 and the GenBank accession numbers are listed in Appendix Table. Our alignments, trees, and Nextstrain outputs are available at: github.com/grubaughlab/DENV-genomics/tree/master/paper_2024-CO.
https://www.github.com/grubaughlab/DENV-genomics/tree/master/paper_2024-CO
